"Hagaha duritaanka irbad-la'aanta ah ee Insulin-ka ee bukaan-socodka macaanka" ayaa lagu sii daayay Shiinaha, taas oo calaamad u ah gelitaanka rasmiga ah ee irbad-la'aanta insulin-ta ee nidaamka bukaan-socodka ee cudurka macaanka ee Shiinaha, waxayna sidoo kale ka dhigtay Shiinaha si rasmi ah waddan loogu talagalay horumarinta tignoolajiyada daaweynta cirbad-la'aanta ah.
Isla mar ahaantaana, waxa dalka oo dhan laga bilaabay kor u qaadida cirbad la’aanta insuliinka, iyo siriinjyo bilaa irbad ah ayaa loo adeegsaday qaybaha boqollaal cusbitaal oo ku yaala dalka Shiinaha, taasoo noqotay qalabkii ugu horeeyay ee irbad la’aan ah oo la dhigo qalab daawaynta.
Sida shirkad hormuud ka berrinkii irbad-free ee Shiinaha, hal-abuurka joogtada ah ee "TECHiJET" technology jet ayaa xaqiiqsaday design model u dhigma ee "TECHIJET" irbad-free makaanikada dareere irbado model oo leh daawooyin kala duwan, iyo xakamaynta saxda ah ee qoto dheer duritaanka iyo meelaha faafinta. , in lala shaqeeyo dawada si loo gaaro bilawga ugu fiican ee ficilka. Sidaa darteed, saliingaha irbad-la'aanta TECHIJET ma aha oo kaliya qalab hordhac oo fudud, laakiin sidoo kale qorshaha daaweynta gudbinta daroogada.
Kahor inta aan la codsan rugta caafimaadka, "TECHIJET" waxay samaysay tiro badan oo tijaabo ah oo tijaabo ah.
The "Pharmacokine ics iyo Pharmacodyna mics Study of Humalog oo aan irbad irbad" oo ay fuliyeen Profess ama Li Qifu oo ka tirsan H ospital koowaad ee Chongqing Medical University ee 2015 ayaa xaqiijiyay in marka la barbar dhigo irbado-free irbad ee "TECHiJET" irbad-free irbadaha insulin ee dhow. qaabka dheecaanka insulinta jireed;
In 2016, daraasadda "Isbarbardhigga saamaynta s ee irbadda -fr ee isku duro ion iyo dhaqameed insu lin pen on bloo d sonkorta dhiigga iyo heerarka insulin ee bukaanada qaba T 2DM" si wadajir ah u fuliyay Professor Xiao Xinhua oo ka tirsan Peking Union Medical College H osp ital iyo Professor Guo Lix ee Isbitaalka Beijing ayaa xaqiijiyay med: "Quwit ick Shure h"
postprandial l xakamaynta sonkorta dhiigga ayaa ka fiican, iyo isbedbeddelka sonkorta dhiigga ka dib ayaa ka yar;
Laga bilaabo 2018, waxay socotay 2 sano waxaana hogaaminayay Profess ama Ji Linong oo ka socda Isbitaalka Peop le's Hospital waxayna si wadajir ah u bilaabeen daraasadda P Hase III oo ay la socdaan 10 ka mid ah xarumaha sare ee hospitaalka. Daraasadda "free" ee la isticmaalayo "T ECHIJET" irbad-fr ee yringe ayaa hadda ah tan ugu weyn adduunka. The res erch us ing tusaha dahabka ah ee dhiiga su gar control "glycat ed hemoglobin" sida waxtarka ugu weyn ee obs er index index, hoos th er es earch ee kooxda khubarada endocrinology ee C hina ee sare, xaqiijiyay faa'iidooyinka "TECHiJET" technology irbad-free res iyo horumarinta ment hal-abuurnimo ee Shiinaha iyo rugaha caafimaadka ma l res earch duritaan irbado t echnology. Daraasadda "BILAASHKA" waxay xaqiijisay gunaanadyada soo socda:
Marka la barbardhigo insulin-ta iyo irbadda h, isbeddelka fr om aasaasiga ah ee HbA1c iyada oo aan irbad lahayn waxay ahayd mid aan ka yarayn insulin p en group, waxayna lahayd heer sare oo tirokoob ah iyo kiliinikada sup eriority. Meesha la isku duro waa yar tahay, mana dhacdo induration; Irbad-fr ee duritaanka ion of insu lin waxay keenaysaa xanuun yar iyo qanacsanaanta bukaanka sare, taas oo hagaajin karta u hoggaansanaanta bukaanka." Waa mas'uuliyadda iyo fikradda "T ECHIJET" si kor loogu qaado e horumarka sayniska iyo tignoolajiyada ee dhaqaalaha caafimaadka qaranka, iyo aragtida "cudur-la'aanta irbad la'aanta waa iyo daaweynta ment, samaynta adduunka meel ka wanaagsan" waxaa hubaal ah in la gaari doono sida ugu dhakhsaha badan.
Waqtiga boostada: Oct-13-2022